placebokontrollierte untersuchung zur wirkung von nikotinsaure auf die dyslipidamie bei metabolischem syndrom und das arterioskleroserisiko (placebo controlled investigation of efficacy of nicotine acid [niacin] on dyslipidaemia in patients with metabolic syndrome and the risk of atherosclerosis).

Trial Profile

placebokontrollierte untersuchung zur wirkung von nikotinsaure auf die dyslipidamie bei metabolischem syndrom und das arterioskleroserisiko (placebo controlled investigation of efficacy of nicotine acid [niacin] on dyslipidaemia in patients with metabolic syndrome and the risk of atherosclerosis).

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Sep 2013

At a glance

  • Drugs Niacin (Primary)
  • Indications Dyslipidaemias
  • Focus Therapeutic Use
  • Sponsors GWT-TUD GmbH
  • Most Recent Events

    • 10 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 May 2009 Additinal lead trial centre added as reported by Clinicaltrials.gov
    • 07 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top